Celgene News

Aug 21, 2008 - Celgene Corporation today announced VIDAZA received expanded U.S. Food and Drug Administration approval to reflect new overall survival achieved in the AZA-001 survival study of patients with ...

Overshadowed by gyrations in the credit, commodity, and energy markets, biotech has been a sleeper with positive returns.

MethylGene Inc. announced that as a result of the internal voluntary suspension of enrollment of new patients into clinical trials evaluating MGCD0103, MethylGene and its development partner, Celgene ...

It has on many occasions allowed be to learn from my mistakes. I have moved the numbers to Google docs so that they are easier to read.

Cancer drug developer MethylGene Inc. says the U.S. Food and Drug Administration is placing a "partial clinical hold" on new patient enrolment for the clinical trial of its lead product for solid tumours and ...

Celgene Subsidiary Pharmion Corporation Withdraws European Marketing Application for Orplatna 8/14/2008 Celgene Europe has told the European Medicines Agency that its Pharmion subsidiary is withdrawing a ...

The North Florida Multiple Myeloma Support Group held its first summer picnic Aug.

Celgene Cellular Therapeutics, which patented a process to harvest stem cells from placentas, is shutting down its Baton Rouge operations and moving out of the Louisiana Technology Park on Florida Boulevard.

Medical Stocks have been showing continued strength with the overall market uncertain if the correction has ended or the current uptrend is just a pause before another leg down for the markets.

Investors were high on health stocks Friday, reestablishing gains for the week's close.

German drugmaker GPC Biotech, which went through a painful downsizing earlier this year to protect its dwindling cash reserves, has suffered another blow.

All rights to these territories will be returned to GPC Biotech. Bernd R. Seizinger, M.D., Ph.D., Chief Executive Officer of GPC Biotech said: "We are disappointed, but we understand Celgene's decision given ...

Healthcare is a hot sector for investors to follow given the growing needs of 77 million baby boomers and its prominent position in the ongoing U.S. presidential race.

Celgene and Novartis v. KV Pharm. , No. 07-4819 KV Pharmaceutical filed an ANDA for a generic version of Ritalin LA with paragraph IV certifications to Celgene's U.S. Patent Nos.

Today's interview is with senior analyst Jason Napodano, who discusses Genentech , Biogen Idec , Gilead , Celgene and Pfizer .

Biotechnology company Celgene Corp. raised its full-year profit and revenue outlook Thursday after reporting a surge in second-quarter sales from its key cancer drug Revlimid.

Guidance Analysts are expecting a profit of 35c on revenue of $538.93M. The consensus range for EPS is 31c to 38c with a revenue range of $517.55M to $561.24M, according to First Call.

MethylGene Inc. and Celgene Corporation today announced that, at the recommendation of a standing internal safety committee, the companies are temporarily suspending enrollment of new patients into clinical ...

Every day, the sun rises on Wall Street, and a plethora of professional analysts wake to issue new opinions on stocks.

Based on the aggregated intelligence of the 110,000 investors participating in Motley Fool CAPS , the Fool's free investing community, biotech company Celgene has earned a coveted five-star ranking .